Companies in #Cancer
Found 1 company operating in this sector.
HUTCHMED
PrivateHUTCHMED is a commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing targeted therapeutics and immunotherapies for cancer and immunological diseases. The company has licensed its dual-action KRAS/EGFR cancer drug to GSK for $110 million upfront.